British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)
复制标题
DOI：
10.1111/j.1468-1293.2006.00424.x
复制
发表时间：
2006-11-01
期刊：
影响因子：
3
通讯作者：
Gazzard, B.
中科院分区：
文献类型：
--
作者：
Gazzard, B.
本文介绍了英国艾滋病协会的指导方针，艾滋病毒感染的成年人的治疗与高效抗逆转录病毒疗法（HAART）。CD4细胞计数、血浆病毒载量和患者年龄是HIV疾病进展风险的决定因素。为了在治疗期间达到最佳效力、依从性和耐受性，HAART方案应个体化。
The article presents the British HIV Association guidelines for the treatment of HIV-infected adults with highly active antiretroviral therapy (HAART). The CD4 cell count, plasma viral load, and the age of the patient are the determinants for the risk of HIV disease progression. In order to achieve the best potency, adherence, and tolerability during treatment, HAART regimens should be individualized.